Here we describe the reactivity of monoclonal antibody (mAb) ER-BMDM1, directed against a 160-kDa cell membrane-associated antigen (Ag) with aminopeptidase activity. The aminopeptidase recognized by ER-BMDMI is present on various mouse macrophage (MQ) and dendritic cell (DC) subpopulations as well as on microvillous epithelia. Analysis of ER-BMDM1 Ag expression in in vitro models of M a maturation revealed that the Ag is expressed at increasing levels upon maturation of MQ. In vivo, high level expression of the ER-BMDM1 Ag occurs after the monocytic stage of maturation, since bone marrow cells and peripheral blood monocytes are essentially ER-BMDM1 negative. Analysis of isolated-resident and elicited MQ populations showed that ER-BMDMI recognizes a specific subpopulation of mature M a : only some resident peritoneal and alveolar MQ are ER-BMDM1 positive, whereas virtually all thioglycollateelicited peritoneal exudate M a bind the mAb. In lymphoid organs, a subpopulation of MQ is recognized as well as interdigitating cells (IDC) located in T cell areas. Phenotypic analysis of isolated DC -the in vitro equivalents of IDC -from spleen and lymph nodes confirmed that the majority of this important antigenpresenting cell population expresses the ER-BMDMI aminopeptidase. The molecular characteristics of the ER-BMDM1 Ag suggest that it may represent the mouse homolog of human CD13.
Introduction
Mature mononuclear phagocytes comprise a very heterogeneous BM-derived cell population. The various representatives perform divergent functions, such as Ag presentation, phagocytosis of senescent cells, and killing of harmful microorganisms and tumor cells (reviewed in [ 1-31). Most of these functions have been studied using in vitro assays on isolated populations and/or cultured cells. It remains difficult, however, to ascribe these functions to specific M a subpopulations located in different tissue compartments. Therefore, a detailed characterization of M a heterogeneity in situ is needed, using markers that are specifically indicative of particular M a functions. mAb directed against M a Ag greatly facilitate defining different M a subpopulations. For instance, ER-TR9 and MOMA-1 recognize two M a subpopulations in the spleen, located at the marginal zone and at the inner border of the marginal sinus, respectively [4, 51. Other mAb, such as F4/80, BM8 or MOMA-2, show broader specificity, yet fail to detect particular MQ subpopulations [6-91. In this report we define a new subpopulation of mature mouse M a , characterized by the binding of mAb ER- [I 10020] * This study was supported by a research grant from the Netherlands Asthma Foundation.
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Materials and methods

Animals, mAb and conjugates
Male and female BALB/c mice were bred at our facility under clean, routine conditions and killed at 10-20 weeks of age. A female F1 (Louvain x Lewis) rat was immunized (see below) and killed as donor of immune spleen cells.
As sources of mAb we used undiluted hybridoma culture supernatants, optimally diluted ascites fluid, or reconstituted purified mAb (BMA Biomedicals AG, Augst, Switzerland). In addition to the ER-BMDMI mAb, described below, we used BM8 (anti-MQ; [S]), ER-MP20 (anti-MQ precursor; [Ill), ER-TR9 (anti-Ma; [4]), F4/80 (anti-Ma; [6] ), H129.19 (anti-CD4; [12] ); M3/38 (anti-Mac-2 M a Ag; [13] ), MOMA-1 (anti-MQ; [S]), MOMA-2 (anti-Ma; [9] ), NLDC-145 (anti-IDC/DC; [14] ), and RA3 6B2 (anti-B-220 B cell Ag; [IS] ).
The hybridoma producing mAb ER-BMDM1 (Erasmus University Rotterdam-BM-derived M a ; IgGza subclass) was generated essentially as described before [Ill, using M a obtained after 7 days from M-CSF stimulated BM culture [16] as the immunogen and rat Y3-Ag1.2.3 myeloma cells as the fusion partner.
The conjugates used in this study were anti-rat Ig coupled to p-galactosidase (Radiochemical Centre, Amersham, GB or Zymed Laboratories, San Francisco, CA; used in ELISA), anti-rat Ig coupled to horseradish peroxidase (Dako, Copenhagen, Denmark; used in immunohistology), and FITC-coupled F(ab')Z fragments of rabbit anti-rat IgG (Cappel, Malvern, PA; used in FCM). 
ELISA, immunofluorescence labeling and FCM analysis
Expression of ER-BMDM1 Ag by MQ cell lines and BM-DM was quantified by a fluorescence micro-ELISA inTerasaki trays as described earlier [16] .
Labeling procedures for immunofluorescence and FCM analysis were performed essentially as described [ l l , 191 . 
Immunoperoxidase staining of cell suspensions and tissue sections
ER-BMDM1 Ag expression by isolated DC was assessed at the single-cell level using an immunoperoxidase assay on cytocentrifuge preparations [20] . Immunoperoxidase staining of cryostat tissue sections was performed essentially as described by de Jong et al. [21] . A hexazotized pararosaniline solution was used for tissue fixation [21] . mAb binding was detected using either a routine diamino-benzidine (DAB) visualization of peroxidase [21] , or a modified protocol involving NiS04-supplemented DAB [22] . In the latter case sections were counterstained with nuclear fast red [22] , whereas sections developed according to the regular DAB method were counterstained with hematoxylin.
Biochemical characterization of the Ag
The molecular mass of the ER-BMDM1 Ag was determined by surface radio-iodination of cells, followed by specific immunoprecipitation and SDS-PAGE analysis, essentially as described by Pont et al. [23] .
Aminopeptidase activity was demonstrated in lysates from P388D1 MQ and small intestine cells, which were obtained by scraping. After isolation, the cells were washed twice in serum-free DMEM and lysed in 1 or 2 ml30 mM TrisHC1, pH 8.0, 1 YO Triton X-100,150 mM NaCl for 30 min on ice.
The lysates were cleared by centrifugation for 15 min at 15 000 X g. Antigens were specifically immunoprecipitated using mAb coupled to anti-rat 1c chain (MARK-1)-coated Sepharose-4B beads [23] . Prior to immunoprecipitation, the lysates were incubated for 2 h with plain MARK-1 beads to remove non-specifically bound proteins. The beads were washed three times in lysate buffer and incubated for 90 min with 0.21 mM leucyl-6-naphthylamide as aminopeptidase substrate in 200 mM phosphate buffer, pH 8.0, supplemented with 0.2 YO Triton X-100. The reaction was stopped by adding 400 p1 1 M NaZC03 to 10 p1 reaction mixture. Generation of the product P-naphthylamine was monitored on a fluorometer, using an excitation wavelength of 340nm and an emission wavelength of 410 nm. mAb reactivity occurs with medullary IDC and with cells associated with cortical and medullary capillaries.
Biochemical characterization of the ER-BMDM1 Ag
The aim of the present study was the developent of mAb against M@ which would help define functional and phenotypic heterogeneity of these cells. mAb ER-BMDM1 was found to recognize an Ag on various M@ subpopulations as well as on microvillous brush borders. The latter finding prompted us to investigate a putative proteolytic function of the Ag.
Immunoprecipitation of the ER-BMDM1 Ag from WR19M. 1 MQ tumor cells and subsequent SDS-PAGE showed that the Ag is a single polypeptide chain of approximately 160 kDa apparent molecular mass (data not shown). Using substrates for enzymes within this size range, we investigated whether immunopurified ERBMDMl Ag possessed any proteolytic activity. Table 1 shows that the ER-BMDM1 mAb precipitated an Ag, from both the P388D1 MQ cell line and small intestine cells, that exhibits leucine aminopeptidase activity. The mAb is, most likely, directed against an epitope distinct from the catalytic site of the enzyme, since addition of the mAb did not influence the observed aminopeptidase activity.
Distribution of ER-BMDM1 aminopeptidase in situ
Lymphoid organs
In the spleen strongly ER-BMDM1-positive cells, presumably M@ [24] , surround the central arteriole (Fig. la) . In the T cell area (periarteriolar lymphocyte sheath; PALS), IDC and PALS MQ are stained. Scattered irregularly shaped cells, distinct from the marginal metallophilic M@ (Fig. lc) , are present at the inner border of the marginal sinus. Immunofluorescence double labeling (not shown) using the IDC marker NLDC-145 and the marginal metallophilic M@ marker MOMA-1 confirmed these observations. In the splenic red pulp, two ER-BMDM1-positive cell types are present. First, patches of irregularly shaped cells are seen at the periphery of the marginal zone (Fig. la) . In addition to ER-BMDM1 Ag, these cells express BM8, F4/80, MOMA-2, and Mac-2 Ag (de Jong and Leenen, manuscript in preparation). Based on the cellular morphology, phenotype and localization, we propose to designate these cells as "marginal red pulp M@". The second population of ER-BMDM1-positive cells in the red pulp is a small subpopulation of "classical" red pulp M@, located deeper in the red pulp.
In the mesenteric LN stretched M@, lining the inside of the LN capsule are clearly ER-BMDM1 positive (Fig. le) . ER-BMDM1-positive IDC are easily detected in the paracortex (T cell area). In the LN medulla, positive M@ are located primarily within the medullary cords. These cells are clearly distinct from the ER-TR9-positive sinus M@ (cf. Fig. l g and h) .
In the thymus, cells, probably M@ [24] , on the inside of the thymic capsule and lining the connective tissue septa show a variable staining pattern (Fig. 2) . In the cortex and corticomedullary junction, most but not all acid phosphatasepositive MQ are recognized by ER-BMDM1. Furthermore,
Non-lymphoid organs
Villous epithelial cells in the small intenstine are heavily labeled, especially at the brush border (Fig. 3a) .The lamina propria in the villi contains only a few scattered positive cells. In contrast, in the large intestine the epithelial cells are negative, whereas the numerous M a in the lamina propria are clearly positive (Fig. 3b) .
Strong ER-BMDM1 staining in the liver appears to be associated with the microvillous brush borders of bile capillaries (Fig. 3c) . The acid phosphatase positive Kupffer cells are negative.
In the lung, there are two ER-BMDM1-positive cell types (Fig. 3d) . Stretched cells surround blood vessels, and, at lower density, bronchi. Furthermore, type-I1 pneumocytes that express microvilli are also positive. Most alveolar MQ are negative.
ER-BMDM1 aminopeptidase expression by isolated DC and MQ populations
To BM M@ precursors and peripheral blood monocytes express little ER-BMDM1 Ag (Fig. 4A) . In contrast, approximately 60% and 30% of the M@ in the resident peritoneal and alveolar cell populations, respectively, readily express this marker. Remarkably, virtually all thioglycollate-elicited peritoneal exudate M@ are strongly ERBMDMl positive. The small positive population present in the granulocytic exudate, isolated 18 h after thioglycollate injection, most likely represents the contribution of remaining resident peritoneal MQ. Together, these data indicate that ER-BMDM1 recognizes a particular subpopulation of DC and M@.
ER-BMDM1 aminopeptidase expression in the course of MT maturation
The observation that BM M@ precursors and peripheral blood monocytes expressed little ER-BMDM1 Ag prompted us to investigate the onset of Ag expression during M@ maturation in more detail. Screening of ERBMDMl reactivity on a panel of MQ cell lines, arrested in distinct, characterized stages of maturation [ 171, revealed that only cell lines with mature M@ characteristics were recognized (Fig. 4B) . In M-CSF-stimulated BM cultures, mAb binding was hardly detectable on nonadherent M@ precursors isolated after 4 days, whereas mature M@ isolatcd aftcr 7 days strongly expressed the ER-BMDMl Ag (Fig. 4B) ( Fig. 4B ). Taking these results together, we conclude that the ER-BMDM1 aminopeptidase is expressed increasingly beyond the monocytic stage in a strict maturation-related man n c r.
Discussion
The data presented in this report indicate that mAb ER-BMDM1 binds to an aminopeptidase at the cell surface of mouse M a , D C and microvillous epithelia. Moreover, the ER-BMDM1 Ag is expressed in increasing amounts as M a mature beyond the monocyticstage. Our finding thatwithin the hemopoietic lineage -only DC/IDC and a M a subpopulation express the ER-BMDMl Ag, contributes to the evidence for a close phenotypic relationship between these cell types [9, 20, 251 [31] and aminopeptidase N [32] . We base this identification on the similar linkage between M a maturation stage and expression of leucine aminopeptidase [33] as well as on the similarity in tissue distribution of aminopeptidase N and the ER-BMDM1 Ag [32] . Recently it was recognized that the human CD13 Ag exhibits aminopeptidase N activity [34, 351.The similarity in both molecular mass and enzyme activity suggests that the Ag recognized by ER-BMDM1 is the mouse homolog of human CD13. However, CD13 Ag is expressed by immature human myeloid cells and granulocytes [36] , in contrast t o the mouse ER-BMDM1 Ag.
